Thursday , September 21 2017
Home / Tag Archives: Coagulation Factor IX

Tag Archives: Coagulation Factor IX

June, 2017

  • 1 June

    FDA Approves New Novo Nordisk Hemophilia B Treatment

    PLAINSBORO, N.J., May 31, 2017 /PRNewswire/ — Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application for REBINYN® (Coagulation Factor IX (Recombinant), GlycoPEGylated) for the treatment of adults and children with hemophilia B. Hemophilia B is a chronic and inherited bleeding …

March, 2016